Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Rezolute Inc (RZLT)

Rezolute Inc (RZLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rezolute Inc 275 Shoreline Drive Suite 500 Redwood City CA 94065 USA

www.rezolutebio.com P: 650-206-4507

Description:

Rezolute, Inc. is a biopharmaceutical company specializing in the development of drug therapies for metabolic and orphan diseases. The Company's products include AB101, RZ358, RZ402 and RZ602 which are in clinical stage. Rezolute, Inc., formerly known as AntriaBio, Inc., is based in LOUISVILLE, United States.

Key Statistics

Overview:

Market Capitalization, $K 102,728
Enterprise Value, $K 86,688
Shares Outstanding, K 40,128
Annual Sales, $ 0 K
Annual Net Income, $ -51,790 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -13,910 K
EBIT, $ -62,480 K
EBITDA, $ -63,820 K
60-Month Beta 1.29
% of Insider Shareholders 20.80%
% of Institutional Shareholders 82.97%
Float, K 31,781
% Float 79.20%
Short Volume Ratio 0.39

Growth:

1-Year Return 22.79%
3-Year Return -57.69%
5-Year Return -70.50%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.27 on 02/13/24
Latest Earnings Date 05/16/24 [--]
Earnings Per Share ttm -1.10
EPS Growth vs. Prev Qtr 3.57%
EPS Growth vs. Prev Year -3.85%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 10/13/20

RZLT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -56.07%
Return-on-Assets % -51.53%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.16
Book Value/Share 2.31
Interest Coverage -3.25
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar